Spots Global Cancer Trial Database for Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome
Official Title: Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome
Study ID: NCT01748448
Conditions
Study Description
Brief Summary: To assess whether vitamin D supplementation after surgery of a first cutaneous malignant melanoma protects against relapse of the disease.
Detailed Description: To assess whether vitamin D supplementation, in the follow up period after diagnosis and surgery of a first cutaneous malignant melanoma, has a protective effect on relapse of cutaneous malignant melanoma and whether this protective effect correlates with vitamin D levels in serum and vitamin D receptor (VDR) immunoreactivity in the primary tumor.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Universitair Ziekenhuis Antwerpen, Dermatology, Edegem, , Belgium
UZLeuven Gasthuisberg, Leuven, , Belgium
Chef de Service du Service Universitaire de Dermatologie, Liège, , Belgium
Dep. of Dermatology, Medical and Health Science Center University of Debrecen, Debrecen, , Hungary
Contact Details
Name: Marjan Garmyn, MD, PhD
Affiliation: Universitaire Ziekenhuizen KU Leuven
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
